May Measurement Month 2021: an analysis of blood pressure screening results from the Philippines

The Philippine Society of Hypertension (PSH) took part again in the annual May Measurement Month 2021 (MMM21) blood pressure (BP) campaign to raise awareness of hypertension. The MMM standard protocol designed by the MMM coordinating centre was used during screening. These included the collection of...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European heart journal supplements 2024-07, Vol.26 (Suppl 3), p.iii75-iii78
Hauptverfasser: Mina, Arnold Benjamin C, David-Ona, Deborah Ignacia, Bonzon, Dolores D, Vilela, Gilbert C, Balmores, Benjamin A, Co, Marlon T, Mercado-Asis, Leilani B, Castillo, Rafael R, Abasolo-Lao, Evelyn M, Dela Cruz, Peter Bryan, Rabago, Norman Panfilo G, Poulter, Neil R, Beaney, Thomas, Clarke, Jonathan M, Diaz, Alejandro Bimbo F
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The Philippine Society of Hypertension (PSH) took part again in the annual May Measurement Month 2021 (MMM21) blood pressure (BP) campaign to raise awareness of hypertension. The MMM standard protocol designed by the MMM coordinating centre was used during screening. These included the collection of basic data on demography, lifestyle, and environmental factors. Standardized sitting BP measurements were taken three times, using automated BP apparatus and were either entered via MMM21 app, MMM@Home, and Google Forms or recorded on paper and transferred to Excel spreadsheets by PSH encoders. Hypertension was defined either as systolic BP ≥ 140 mmHg or diastolic BP ≥ 90 mmHg or on antihypertensive medication. A total of 59 655 participated through opportunistic convenience sampling. After multiple imputation, a total of 26 813 (44.9%) participants were identified as having hypertension. Of these, 14 449 (53.9%) were aware and 12 978 (48.4%) were on antihypertensive medication. Of those who were treated, 5644 (43.5%) had controlled BP (
ISSN:1520-765X
1554-2815
DOI:10.1093/eurheartjsupp/suae066